Ying-cheng H. Chiang

Ying-cheng H. Chiang

Hsinchu, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Tamoxifen Use and Risk of Uterine Diseases in Young Women With Breast Cancer.

Tamoxifen Use and Risk of Uterine Diseases in Young Women With Breast Cancer.

Journal: Obstetrics and gynecology

Published: July 16, 2026

Regarding "When Performing vNOTES Salpingectomy, Are We Damaging the Ovarian Reserve? Results From a Randomized, Controlled Trial".

Regarding "When Performing vNOTES Salpingectomy, Are We Damaging the Ovarian Reserve? Results From a Randomized, Controlled Trial".

Journal: Journal of minimally invasive gynecology

Published: March 02, 2026

Is it niche healing or just amenorrhea? Re-interpreting the superiority of LNG-IUS (Letter-to-the-Editor).

Is it niche healing or just amenorrhea? Re-interpreting the superiority of LNG-IUS (Letter-to-the-Editor).

Journal: American journal of obstetrics and gynecology

Published: February 10, 2026

Survival outcomes and time toxicity of Sandwich versus Sequential chemoradiation in Stage III endometrial cancer: A real-world study stratified by molecular classification.

Survival outcomes and time toxicity of Sandwich versus Sequential chemoradiation in Stage III endometrial cancer: A real-world study stratified by molecular classification.

Journal: Gynecologic oncology

Published: December 17, 2025

A potential mutation-defined POLE/MMR/TP53 group classifications to stratify BRCA wild type epithelial ovarian cancer.

A potential mutation-defined POLE/MMR/TP53 group classifications to stratify BRCA wild type epithelial ovarian cancer.

Journal: Journal of ovarian research

Published: December 10, 2025

Response to: Pembrolizumab in advanced endometrial cancer: Dosing equivalence and molecular insights from an Asian cohort.

Response to: Pembrolizumab in advanced endometrial cancer: Dosing equivalence and molecular insights from an Asian cohort.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: December 10, 2025

Uncoupling anatomical barriers from radiotherapy toxicity: a two-part hurdle analysis of sexual function in gynecologic cancer.

Uncoupling anatomical barriers from radiotherapy toxicity: a two-part hurdle analysis of sexual function in gynecologic cancer.

Journal: The journal of sexual medicine

Published: December 09, 2025

Development of a novel multimodal deep learning approach to improve diagnostic precision in ovarian cancer.

Development of a novel multimodal deep learning approach to improve diagnostic precision in ovarian cancer.

Journal: Briefings in bioinformatics

Published: October 02, 2025

Deep spatial transcriptomic profiling of ovarian clear cell carcinoma in the real-world setting.

Deep spatial transcriptomic profiling of ovarian clear cell carcinoma in the real-world setting.

Journal: Journal of ovarian research

Published: September 27, 2025

BTLA: An Emerging Immune Checkpoint Target in Cancer Immunotherapy.

BTLA: An Emerging Immune Checkpoint Target in Cancer Immunotherapy.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 18, 2025

Free-floating trophoblastic cyst in chemo-resistant gestational trophoblastic neoplasm.

Free-floating trophoblastic cyst in chemo-resistant gestational trophoblastic neoplasm.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 17, 2025

Development of INER-PP-F11N as the Peptide-Radionuclide Conjugate Drug Against CCK2 Receptor-Overexpressing Tumors.

Development of INER-PP-F11N as the Peptide-Radionuclide Conjugate Drug Against CCK2 Receptor-Overexpressing Tumors.

Journal: International journal of molecular sciences

Published: May 31, 2025

Showing 1-12 of 73

Last Updated: 09/26/2026